Abstract | BACKGROUND: METHODS: Seventy-nine patients with moderate pain after third molar extraction under general anaesthesia were randomized to receive a 15 min double-blind infusion containing either GR79236X 4 microg kg-1, GR79236X 10 microg kg-1, diclofenac 50 mg, or saline placebo. Rescue analgesia was promptly available to all patients. RESULTS: Meaningful pain relief (mild or no pain) was attained by 9 (47%) patients in the placebo group, 12 (63%) patients in the GR79236 4 microg kg-1 group, 10 (48%) patients in the 10 microg kg-1 group, and 16 (80%) patients in the diclofenac 50 mg group. Neither dose of GR79236 produced a significant improvement over placebo, but diclofenac was superior to both placebo (P=0.036) and GR79236 10 microg kg-1 (P=0.034). Median times to rescue or additional analgesia were 62, 100, 60, and 363 min for patients receiving placebo, GR79236 4 microg kg-1, 10 microg kg-1, and diclofenac 50 mg, respectively ( diclofenac significantly longer than placebo, P=0.002 log-rank test). Pain control was poor in the placebo group and in both GR79236 groups, with between 79 and 86% of patients having good pain control (i.e. mild or no pain) for <20% of the time compared with only 30% of patients who received diclofenac. CONCLUSION: We found no evidence of efficacy of GR79236 compared with placebo, but the active control diclofenac was effective. It is possible that a higher dose of GR79236 might have been effective or that i.v. administration of this drug does not achieve appropriate concentrations in the brain or peripheral nerves.
|
Authors | J R Sneyd, J A Langton, L G Allan, J E Peacock, D J Rowbotham |
Journal | British journal of anaesthesia
(Br J Anaesth)
Vol. 98
Issue 5
Pg. 672-6
(May 2007)
ISSN: 0007-0912 [Print] England |
PMID | 17416906
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents, Non-Steroidal
- Purinergic P1 Receptor Agonists
- Diclofenac
- Adenosine
- N-((1S,trans)-2-hydroxycyclopentyl)adenosine
|
Topics |
- Adenosine
(administration & dosage, analogs & derivatives, therapeutic use)
- Adolescent
- Adult
- Analgesics, Non-Narcotic
(administration & dosage, therapeutic use)
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Diclofenac
(therapeutic use)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Molar, Third
(surgery)
- Pain Measurement
(methods)
- Pain, Postoperative
(drug therapy, etiology)
- Purinergic P1 Receptor Agonists
- Tooth Extraction
(adverse effects)
|